A correlation between symptom severity and unbalanced reactive IgA production in Japanese cedar pollinosis patients

Asian Pacific Journal of Allergy and Immunology

Volumn 26, Issue 2-3, 2008, Pages 97-104

  Komatsu, Nobukazu ^a   Harada, Mamoru ^a,b,c   Nakagawa, Masami ^a,d   Tanaka, Yasuaki ^a   Ono, Takeharu ^a   Gohara, Shojiro ^b   Ohkubo, Kimihiko ^e   Itoh, Kyogo ^a,b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d ImmunoDia Inc   (Japan)

^e NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRY J 1 PROTEIN; CRY J 2 PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; POLLEN ANTIGEN; UNCLASSIFIED DRUG; VEGETABLE PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; JAPANESE CEDAR; MAJOR CLINICAL STUDY; MALE; POLLEN; POLLEN ALLERGY; SCORING SYSTEM;

ADULT; ALLERGENS; ANTIBODY FORMATION; CRYPTOMERIA; DISEASE PROGRESSION; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; MALE; PLANT PROTEINS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX;

EID: 58149469073     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Yasueda H, Yi Y, Shimizu T, Shida T. Isolation and partial characterization of the major allergen from Japanese cedar ( Cryptomeria japonica) J Allergy Clin Immunol 1983; 71: 77-86.
2. Sakaguchi M, Inouye S, Taniai S, Ando M, Usui M, Matuhasi. Identification of the second major allergen of Japanese cedar pollen. Allergy 1990; 43: 309-12.
3. Griffith IJ, Lussir JA, Garman R, Koury R, Yeung H, Pollock. cDNA cloning of Cry j I, the major allergen of Cryptomeria japonica (Japanese cedar). J Allergy Clin Immunol 1993; 91: 339 (Abstr.).
4. Sone T, Komiyama N, Shimizu K, Kusakabe T, Morikubo K, Kino K. Cloning and sequencing of cDNA coding for Cry j I, a major allergen of Japanese cedar pollen. Biochem Biophys Res Commun 1994; 199: 619-25.
5. Hashimoto M, Nigi H, Sakaguchi M, Inouye S, Imaoka K, Miyazawa H, Taniguchi Y, Kurimoto M, Yasueda H, Ogawa T. Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar ( Cryptomeria japonica) pollinosis. Clin Exp Allergy 1995; 25: 848-52.
6. Japanese cedermura K, Hashiguchi S, Takahashi Y, Hino K, Taniguchi Y, Kurimoto M, Fukuda K, Ohyama M, Yamada G. Th1/Th2 response profiles to the major allergens Cry j I and Cry j 2 of Japanese cedar pollen. Allergy 1996; 51: 732-40.
7. Sone T, Morikubo K, Miyahara M, Komiyama N, Shimizu K, Tsunoo H, Kino K. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis. J Immunol 1998; 161: 448-57.
8. Tamura Y, Sasaki R, Inouye S, Kawaguchi J, Serizawa N, Toda M, Takemori T, Sakaguchi M. Identification of a sequential B-cell epitope on major allergen (Cry j 1) of Japanese cedar (Cryptomeria japonica) pollen in mice. Int Arch Allergy Immunol 2000; 123: 228-35.
9. Yoshitomi T, Hirahara K, Kawaguchi J, Serizawa N, Taniguchi Y, Saito S, Sakaguchi M, Inouye S, Shiraishi A. Three T-cell determinants of Cry j 1 and Cry j 2, the major Japanese Cedar pollen antigens, retain their immunogenicity and tolerogenicity in a linked peptide. Immunology 2002; 107: 517-22.
10. Takagi K, Teshima R, Sawada J. Determination of human linear IgE epitopes of Japanese cedar allergen Cry j 1. Biol Pharm Bull 2005; 28: 1496-9.
11. Tilley SL, Jaradat M, Stapleton C, Dixon D, Hua X, Erikson CJ, McCaskill JG, Chason KD, Liao G, Jania L, Koller BH, Jetten AM. Retinoid-related orphan receptor gamma controls immunoglobulin production and Th1/Th2 cytokine balance in the adaptive immune response to allergen. J Immunol 2007; 178: 3208-18.
12. Komatsu N, Shichijo S, Nakagawa M, Itoh K. New multiplexed flow cytometric assay to measure anti-peptide antibody: a novel tool for monitoring immune responses to peptides used for immunization. Scand J Clin Invest 2004; 64: 1-11.
13. Bousquet J, Lockey R, Malling HJ. Allergen therapeutic vaccination for allergic disease. A WHO position paper. J Allergy Clin Immunol 1998; 102: 558-62.
14. Russell MW, Kilian M, Lamm ME. Biological activities of IgA. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienestecky J, McGhee JR, eds. Mucosal Immunology, 2nd edition, San Diego: Academic Press, 1999; pp. 225-52.
15. Daniel C, Repa A, Wild C, Pollak A, Pot B, Breiteneder H, Wiedermann U, Mercenier A. Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet V 1. Allergy 2006; 61: 812-9.
16. Moller C, Dreborg S, Lanner A, Bjorksten S. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy: a double blind study. Allergy 1986; 41: 271-9.
17. Taudorf E, Moller C, Russell MW. Secretary IgA response in oral immunotherapy. Investigation in birch pollinosis. Allergy 1994; 49: 760-5.
18. Urbanck R, Burgelin KH, Kahle S, Kuhn W, Wahn U. Oral immunotherapy with grass pollen in enterosoluble capsules: a prospective study of the clinical and immunological response. Eur J Pediatr 1990; 149: 545-50